Measurement of glial fibrillary acidic protein in blood: An analytical method

Clinica Chimica Acta

Volumn 326, Issue 1-2, 2002, Pages 151-154

  Van Geel, Wieneke J A ^a   De Reus, Herman P M ^a   Nijzing, Henk ^b   Verbeek, Marcel M ^a   Vos, Pieter E ^a   Lamers, Karel J B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Byk Nederland BV   (Netherlands)

Author keywords

Blood values; Glial fibrillary acidic protein; Severe traumatic brain injury

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; BRAIN INJURY; CALIBRATION; METHODOLOGY; MIDDLE AGED; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADULT; AGED; BIOLOGICAL MARKERS; BRAIN INJURIES; CALIBRATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; LINEAR MODELS; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0036890296     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00330-3     Document Type: Article

References (10)

1. Endo E., Tanaka T., Isoke T., Kasai H., Okuyama T., Hidaka H. Calcium-dependent affinity chromatography of S-100 and calniodulin antagonist coupled sepharose. J. Biol. Chem. 256:1981;12485-12489.
2. Abraha H.D., Butterworth R.J., Bath P.M., Garthwaite J., Sherwood R.A. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann. Clin. Biochem. 34:1997;366-370.
3. Herrmann M., Curio N., Jost S., Wunderlich M., Synowitz H., Wallesch C. Protein S-100b and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Res. Neurol. Neurosci. 14:1999;109-114.
4. Eng L.F., Vanderhaeghen J.J., Bignami A., Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res. 28:1971;351-354.
5. Duchen L.W. General pathology of neurons and neuroglia. Adams J.H., Corsellis J.A.N., Duchen L.W. Greenfield's neuropathology. 1984;1-52 Edward Arnold, London.
6. Noppe M., Crols R., Andries D., Lowenthal A. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology. Clin. Chim. Acta. 155:1986;143-150.
7. Aurell A., Rosengren L.E., Karlsson B., Olsson J.E., Zbornikova V., Haglid K.G. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke. 22:1991;1254-1258.
8. Rosengren L., Wikkelso C., Hagberg L. A sensitive ELISA for glial acidic protein: application in CSF of adults. J. Neurosci. Methods. 51:1994;197-204.
9. Missler U., Wiesmann M., Wittmann G., Magerkurth O., Hagenstrom H. Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin. Chem. 45:1999;138-141.
10. Herrmann M., Vos P.E., Wunderlich M.T., de Bruijn Ch.H.M.M., Lamers K.J.B. Release of glial tissue-specific proteins after acute stroke. A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke. 31:2000;2670-2677.